IMI - Clinical Management Guidelines Report.
Clicks: 329
ID: 50825
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Star Article
83.3
/100
329 views
263 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, and optical and pharmacologic treatments, as well as skills to translate the risks and benefits of a given myopia control treatment into lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable, and the progressing myope, including risk factor identification, examination, selection of treatment strategies, and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment, and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources, and recommendations for continuing professional education in this growing area of clinical practice.Reference Key |
gifford2019imiinvestigative
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Gifford, Kate L;Richdale, Kathryn;Kang, Pauline;Aller, Thomas A;Lam, Carly S;Liu, Y Maria;Michaud, Langis;Mulder, Jeroen;Orr, Janis B;Rose, Kathryn A;Saunders, Kathryn J;Seidel, Dirk;Tideman, J Willem L;Sankaridurg, Padmaja; |
Journal | investigative ophthalmology & visual science |
Year | 2019 |
DOI | 10.1167/iovs.18-25977 |
URL | |
Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.